As of 2025-07-11, the EV/EBITDA ratio of EyePoint Pharmaceuticals Inc (EYPT) is -4.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EYPT's latest enterprise value is 675.88 mil USD. EYPT's TTM EBITDA according to its financial statements is -159.64 mil USD. Dividing these 2 quantities gives us the above EYPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 10.4x | 8.3x |
| Forward P/E multiples | 11.4x - 17.8x | 15.0x |
| Fair Price | (25.26) - (22.94) | (25.85) |
| Upside | -328.4% - -307.4% | -333.7% |
| Date | EV/EBITDA |
| 2025-07-10 | -4.23 |
| 2025-07-09 | -4.19 |
| 2025-07-08 | -3.76 |
| 2025-07-07 | -3.56 |
| 2025-07-03 | -3.66 |
| 2025-07-02 | -3.63 |
| 2025-07-01 | -3.58 |
| 2025-06-30 | -3.52 |
| 2025-06-27 | -3.62 |
| 2025-06-26 | -3.94 |
| 2025-06-25 | -4.01 |
| 2025-06-24 | -3.42 |
| 2025-06-23 | -3.04 |
| 2025-06-20 | -3.10 |
| 2025-06-18 | -3.31 |
| 2025-06-17 | -3.26 |
| 2025-06-16 | -3.30 |
| 2025-06-13 | -3.36 |
| 2025-06-12 | -3.29 |
| 2025-06-11 | -3.26 |
| 2025-06-10 | -3.44 |
| 2025-06-09 | -3.32 |
| 2025-06-06 | -3.32 |
| 2025-06-05 | -3.02 |
| 2025-06-04 | -3.00 |
| 2025-06-03 | -2.97 |
| 2025-06-02 | -2.66 |
| 2025-05-30 | -2.59 |
| 2025-05-29 | -2.57 |
| 2025-05-28 | -2.50 |
| 2025-05-27 | -2.04 |
| 2025-05-23 | -1.91 |
| 2025-05-22 | -1.88 |
| 2025-05-21 | -2.00 |
| 2025-05-20 | -2.14 |
| 2025-05-19 | -2.10 |
| 2025-05-16 | -2.11 |
| 2025-05-15 | -1.93 |
| 2025-05-14 | -1.83 |
| 2025-05-13 | -2.01 |
| 2025-05-12 | -1.99 |
| 2025-05-09 | -1.97 |
| 2025-05-08 | -2.10 |
| 2025-05-07 | -2.09 |
| 2025-05-06 | -2.16 |
| 2025-05-05 | -2.42 |
| 2025-05-02 | -2.61 |
| 2025-05-01 | -2.54 |
| 2025-04-30 | -2.41 |
| 2025-04-29 | -2.33 |